Fig. 1
From: B7-H3 and ICAM-1 are potentially therapeutic targets for thyroid carcinoma
Expression levels of B7-H3 and ICAM-1 mRNA in thyroid carcinoma (THCA) in the TCGA cohort. A. B7-H3 mRNA expression between normal thyroid tissue samples (n = 59) and thyroid cancer tissue samples (n = 505). B. B7-H3 mRNA expression of tumor tissues with different tumor histology. C. B7-H3 mRNA expression of tumor tissues with different tumor stages. D. B7-H3 mRNA expression of tumor tissues with different patient's age. E. B7-H3 mRNA expression of tumor tissues with different nodal metastasis status. F. B7-H3 mRNA expression of tumor tissues with patient's gender. G. ICAM-1 mRNA expression between normal thyroid tissue samples (n = 59) and thyroid cancer tissue samples (n = 505). H. ICAM-1 mRNA expression of tumor tissues with different tumor histology. I. ICAM-1 mRNA expression of tumor tissues with different tumor stages. J. ICAM-1 mRNA expression of tumor tissues with different patient's age. K. ICAM-1 mRNA expression of tumor tissues with different nodal metastasis status. L. ICAM-1 mRNA expression of tumor tissues with patient's gender